-transparent.png){kind=logo}
The binding of different synthetic steroids, used in hormonal contraception, to Sex Hormone Binding Globulin (SHBG) was studied by measuring their ability to displace tritiated testosterone from SHBG in a competitive protein binding system. Only 19-nortestosterone derivates had any significant ability to displace testosterone from SHBG, d-norgestrel (d-Ng) being the strongest displacer. Increasing the SHBG levels in women with previous constant plasma d-Ng levels increased these levels two- to sixfold. It is concluded that SHBG is the main carrier protein for d-Ng. The strong testosterone displacing activity of d-Ng might also explain androgenic side effects observed with d-Ng containig oral contraceptives.
A Victor, and
E Weiner, and
E D Johansson
January 1977,
Contraception,
A Victor, and
E Weiner, and
E D Johansson
November 1983,
Ugeskrift for laeger,
A Victor, and
E Weiner, and
E D Johansson
January 1974,
Clinical endocrinology,
A Victor, and
E Weiner, and
E D Johansson
March 1995,
Nihon rinsho. Japanese journal of clinical medicine,
A Victor, and
E Weiner, and
E D Johansson
December 1999,
Nihon rinsho. Japanese journal of clinical medicine,
A Victor, and
E Weiner, and
E D Johansson
July 2010,
Nihon rinsho. Japanese journal of clinical medicine,
A Victor, and
E Weiner, and
E D Johansson
August 1982,
Lancet (London, England),
A Victor, and
E Weiner, and
E D Johansson
August 2005,
Nihon rinsho. Japanese journal of clinical medicine,
A Victor, and
E Weiner, and
E D Johansson
June 1995,
The Journal of steroid biochemistry and molecular biology,
A Victor, and
E Weiner, and
E D Johansson
January 1988,
Annals of the New York Academy of Sciences,
